Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-01-15

FDA Approved: ELETRIPTAN HYDROBROMIDE — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved the original abbreviated new drug application for Eletriptan hydrobromide (generic) from Aurobindo Pharma Limited. The approval authorizes Eletript…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Eletriptan Hydrobromide (eletriptan hydrobromide)

Snippet

ORIG AP for ELETRIPTAN HYDROBROMIDE (ELETRIPTAN HYDROBROMIDE)